Sanofi (SNY) EPS (Basic) (QoQ) (2009 - 2026)
Powered by 
Analysis
Sanofi (SNY) EPS (Basic) (QoQ) (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 642.60 Bn | 621.84 Bn | 17.26 Bn |
| 2 | AbbVie | 447.11 Bn | 440.55 Bn | 12.70 Bn |
| 3 | Merck | 358.25 Bn | 351.11 Bn | 12.21 Bn |
| 4 | Novartis Ag | 267.57 Bn | 259.88 Bn | 11.24 Bn |
| 5 | Pfizer | 156.64 Bn | 144.94 Bn | 10.94 Bn |
| 6 | Sanofi | 52.20 Bn | 44.82 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 42.91 Bn | 42.91 Bn | - |
| 8 | Incyte | 24.64 Bn | 20.11 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.56 Bn | 18.90 Bn | 683.80 Mn |
| 10 | Neurocrine Biosciences | 15.82 Bn | 15.43 Bn | 935.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -78.90% |
| Mar 31, 2026 | 124.55% |
| Dec 31, 2025 | -176.44% |
| Sep 30, 2025 | 125.79% |
| Jun 30, 2025 | 132.25% |
| Mar 31, 2025 | 269.28% |
| Dec 31, 2024 | -82.75% |
| Sep 30, 2024 | 157.93% |
| Jun 30, 2024 | -2.62% |
| Mar 31, 2024 | 306.12% |
| Dec 31, 2023 | -121.73% |
| Sep 30, 2023 | 75.90% |
| Jun 30, 2023 | -27.03% |
| Mar 31, 2023 | -60.10% |
| Dec 31, 2022 | 156.50% |
| Sep 30, 2022 | 66.95% |
| Jun 30, 2022 | -44.39% |
| Mar 31, 2022 | -61.15% |
| Dec 31, 2021 | 113.26% |
| Sep 30, 2021 | 88.82% |